HomeNewsTrendsFeaturesCoronavirus pandemic: How women entrepreneurs are riding out the COVID-19 lockdown in India

Coronavirus pandemic: How women entrepreneurs are riding out the COVID-19 lockdown in India

As COVID-19 puts a halt to the wheels of economies worldwide, five entrepreneurs and self-employed women in India share their experiences.

May 09, 2020 / 09:28 IST
Story continues below Advertisement

The impact of the COVID-19 pandemic is unimaginable. It has put global governments in a quandary, businesses in a fix, and revealed the cracks in social and economic systems that prioritise corporate profit and defence expenditure over health, education and social welfare.

Besides the lives lost, the coronavirus pandemic of 2020 will leave an indelible mark in history for the global lockdowns it has triggered. For sure, micro, small and medium enterprises (MSMEs) will be the worst hit by the lockdown in India. This is disquieting as 6.3 crore non-agricultural MSMEs in India employ 11 crore people, who will now shoulder the major brunt of the lockdown and, many predict, will not be able to reach pre-lockdown revenues for months or even years.

Story continues below Advertisement

In a scenario where men dominate the labour force, where women earn only 80 percent of male wages for the same work, and where women spend 577 percent more time on unpaid domestic work than men, the few women who own or run enterprises are outliers and pathbreakers. Women own 20 percent of micro enterprises, 5 percent small enterprises, and less than 3 percent medium enterprises in India. Economic slowdowns and pandemic-induced shutdowns will hit them the hardest too.

We speak to five women across sectors to understand the lockdown’s impact on their business. For sure there is loss, but could there be a course-correction and opportunity too in this crisis?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show